Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Nexvet Biopharma (NVET) Jumps: Stock Moves 9.2% Higher
Nexvet Biopharma Public Limited Company was a big mover last session, as its shares rose over 9% on the day. The upside was driven by the presentation of expanded positive clinical data for ranevetmab and frunevetmab. This also led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up over 46% in the past one month time frame.
Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Nexvet Biopharma currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
A better-ranked biomedical stock is ANI Pharmaceuticals, Inc. (ANIP - Free Report) which sports a Zacks Rank #1 (Strong Buy).
Is NVET going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>